Edwards Lifesciences Balance Sheet Health
Financial Health criteria checks 6/6
Edwards Lifesciences has a total shareholder equity of $6.7B and total debt of $597.0M, which brings its debt-to-equity ratio to 8.9%. Its total assets and total liabilities are $9.4B and $2.6B respectively. Edwards Lifesciences's EBIT is $1.7B making its interest coverage ratio -34.9. It has cash and short-term investments of $1.6B.
Key information
8.9%
Debt to equity ratio
US$597.00m
Debt
Interest coverage ratio | -34.9x |
Cash | US$1.64b |
Equity | US$6.72b |
Total liabilities | US$2.64b |
Total assets | US$9.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EWL's short term assets ($4.0B) exceed its short term liabilities ($1.2B).
Long Term Liabilities: EWL's short term assets ($4.0B) exceed its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: EWL has more cash than its total debt.
Reducing Debt: EWL's debt to equity ratio has reduced from 18.9% to 8.9% over the past 5 years.
Debt Coverage: EWL's debt is well covered by operating cash flow (150.1%).
Interest Coverage: EWL earns more interest than it pays, so coverage of interest payments is not a concern.